1. Home
  2. SBET vs IMCR Comparison

SBET vs IMCR Comparison

Compare SBET & IMCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SharpLink Gaming Ltd.

SBET

SharpLink Gaming Ltd.

HOLD

Current Price

$7.34

Market Cap

1.4B

Sector

Technology

ML Signal

HOLD

Logo Immunocore Holdings plc

IMCR

Immunocore Holdings plc

HOLD

Current Price

$31.64

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SBET
IMCR
Founded
1995
2008
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.5B
IPO Year
2025
2016

Fundamental Metrics

Financial Performance
Metric
SBET
IMCR
Price
$7.34
$31.64
Analyst Decision
Strong Buy
Buy
Analyst Count
8
13
Target Price
$16.63
★ $62.73
AVG Volume (30 Days)
★ 6.0M
474.7K
Earning Date
11-11-2026
11-09-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 30.39
EPS
N/A
★ 0.23
Revenue
$28,055,000.00
★ $249,428,000.00
Revenue This Year
$67.70
$13.06
Revenue Next Year
$57.94
$8.12
P/E Ratio
★ N/A
$135.83
Revenue Growth
★ 666.04
43.05
52 Week Low
$4.46
$27.50
52 Week High
$13.94
$40.71

Technical Indicators

Market Signals
Indicator
SBET
IMCR
Relative Strength Index (RSI) 36.60 51.69
Support Level $6.88 $30.47
Resistance Level $8.20 $31.99
Average True Range (ATR) 0.46 1.22
MACD -0.16 0.43
Stochastic Oscillator 0.26 61.67

Price Performance

Historical Comparison
SBET
IMCR

About SBET SharpLink Gaming Ltd.

Sharplink Inc is one of those publicly traded companies to adopt ETH as its primary treasury reserve asset. This move reflects the Company's commitment to align corporate treasury with the future of programmable finance, digital capital markets, and decentralized infrastructure. The Company also operates an online affiliate marketing company that delivers different fan activation solutions to its sportsbook and online casino gaming partners. The company operates in two reportable segments: ETH Treasury Management and Affiliate Marketing. The majority of its revenue is generated from the ETH Treasury Management. Geographically, the company operates in the United States and the rest of the world.

About IMCR Immunocore Holdings plc

Immunocore Holdings PLC is a commercial-stage biotechnology company. Using its ImmTAX platform, the company is developing a deep pipeline in multiple therapeutic areas, including clinical stage programs in oncology and infectious disease, pre-clinical programs in autoimmune disease, and earlier pre-clinical programs across three therapeutic areas. The company's main product, KIMMTRAK, is used for the treatment of unresectable or metastatic uveal melanoma (mUM). The other drug candidates in its pipeline include Brenetafusp, IMC-P115C, IMC-T119C, IMC-R117C, IMC-S118AI, IMC-U120AI, and others, being developed as a potential treatment for various oncology, infectious, and autoimmune diseases.

Share on Social Networks: